In this line, systemic administration of crotonate prevented the decrease in kidney PGC-1α and SIRT3 levels in AKI (Fig. 6B,C,E,F) as well as the increase in CCL2 mRNA expression (Fig. 6D). This evidence concerns the gene SIRT3 and acute kidney injury.